Inhibitory Effect of Methyleugenol on IgE-Mediated Allergic Inflammation in RBL-2H3 Cells

Allergic diseases, such as asthma and allergic rhinitis, are common. Therefore, the discovery of therapeutic drugs for these conditions is essential. Methyleugenol (ME) is a natural compound with antiallergic, antianaphylactic, antinociceptive, and anti-inflammatory effects. This study examined the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Feng Tang (Egilea), Feilong Chen (Egilea), Xiao Ling (Egilea), Yao Huang (Egilea), Xiaomei Zheng (Egilea), Qingfa Tang (Egilea), Xiaomei Tan (Egilea)
Formatua: Liburua
Argitaratua: Hindawi Limited, 2015-01-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_72dd7ca976d34f0fa7f360ff25d90c0c
042 |a dc 
100 1 0 |a Feng Tang  |e author 
700 1 0 |a Feilong Chen  |e author 
700 1 0 |a Xiao Ling  |e author 
700 1 0 |a Yao Huang  |e author 
700 1 0 |a Xiaomei Zheng  |e author 
700 1 0 |a Qingfa Tang  |e author 
700 1 0 |a Xiaomei Tan  |e author 
245 0 0 |a Inhibitory Effect of Methyleugenol on IgE-Mediated Allergic Inflammation in RBL-2H3 Cells 
260 |b Hindawi Limited,   |c 2015-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1155/2015/463530 
520 |a Allergic diseases, such as asthma and allergic rhinitis, are common. Therefore, the discovery of therapeutic drugs for these conditions is essential. Methyleugenol (ME) is a natural compound with antiallergic, antianaphylactic, antinociceptive, and anti-inflammatory effects. This study examined the antiallergic effect of ME on IgE-mediated inflammatory responses and its antiallergy mechanism in the mast cell line, RBL-2H3. We found that ME significantly inhibited the release of β-hexosaminidase, tumor necrosis factor- (TNF-) α, and interleukin- (IL-) 4, and was not cytotoxic at the tested concentrations (0-100 μM). Additionally, ME markedly reduced the production of the proinflammatory lipid mediators prostaglandin E2 (PGE2), prostaglandin D2 (PGD2), leukotriene B4 (LTB4), and leukotriene C4 (LTC4). We further evaluated the effect of ME on the early stages of the FcεRI cascade. ME significantly inhibited Syk phosphorylation and expression but had no effect on Lyn. Furthermore, it suppressed ERK1/2, p38, and JNK phosphorylation, which is implicated in proinflammatory cytokine expression. ME also decreased cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LO) phosphorylation and cyclooxygenase-2 (COX-2) expression. These results suggest that ME inhibits allergic response by suppressing the activation of Syk, ERK1/2, p38, JNK, cPLA2, and 5-LO. Furthermore, the strong inhibition of COX-2 expression may also contribute to the antiallergic action of ME. Our study provides further information about the biological functions of ME. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 2015 (2015) 
787 0 |n http://dx.doi.org/10.1155/2015/463530 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/72dd7ca976d34f0fa7f360ff25d90c0c  |z Connect to this object online.